Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Bupivacaine vs Ropivacaine for Low Volume US-ISB
NCT02643563Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jan 2016
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine and bupivacaine in postoperative pain (3 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Duration of analgesic block at 48 hours. Started Jan 2016; status: completed.
02
Drugs
ropivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02643563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02643563.